Indication intelligence, analysis and sector perception

Q2/20 Earnings - (LPS - loss-per-share) Results

September 15, 2020

A scorecard of 1 restatement and 1 acquisition of 35 covered  companies The current LPS (loss per share) or net income, cash positions i.e. "runways"  is a reflection of this universe's investing "status"

Adverum Biotechnologies (ADVM) closes $216.8 million offering priced at $3.00

August 12, 2020

16,675 million shares were offered which included an additional 2,175 million underwiter option Goldman Sachs & Co. LLC, Cowen and Company, LLC, SVB Leerink LLC and Piper Sandler & Co. are acting as joint book-running managers for the proposed offering. ADVM is DOWN -$0.16 to $13.55 at closing

BioLife Solutions (BLFS) closes 5.95 million share offering priced at $14.50

July 8, 2020

BLFS' underwriters' option included an additional 776,250 shares The gross proceeds from the offering to BLFS, before deducting underwriting discounts and commissions and estimated offering expenses, were approximately $86 million.